Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-24 @ 6:49 PM
NCT ID:
NCT01935557
Brief Summary:
Optimal anticoagulation using heparin with close attention to maintain therapeutic dosing during the procedure is important.
Randomized comparison of continuous and intermittent heparin infusion during catheter ablation of Atrial Fibrillation.
Detailed Description:
Intravenous heparin was used during the procedure to prevent catheter-induced thrombosis.
heparin is administered during the procedure to achieve recommended activation clotting times (ACT) values, typically \>300 seconds to prevent thromboemboli during the procedure.
Most of the practitioners was that ACT level should be checked at 30- to 60-minute intervals and then have injected intermittently.
intermittent heparin infusion, concentration is great changed because the heparin has 30minutes half-period.
researchers postulate that a constant therapeutic concentrations would be beneficial to continuous infusion than intermittent infusion.
Study:
NCT01935557
Study Brief:
Protocol Section:
NCT01935557